Splenic dysfunction

Chairs

Jacqueline J. Loonen, Radboud University Medical Center, Nijmegen, the Netherlands
Gregory M.T. Guilcher, Alberta Children’s Hospital, Calgary, Canada

Advisors

Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Roderick Skinner, Great North Children’s Hospital and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Louis S. Constine, University of Rochester Medical Center, Rochester, United States
W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
Elvira C. van Dalen, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Coordinator

Bente M. Houtman, Radboud University Medical Center, Nijmegen, the Netherlands

WG leaders

Danielle Novetsky-Friedman, Memorial Sloan Kettering Cancer Center, New York, United States

WG members

Edit Bardi, Kepler Universitätsklinicum MCIV, Linz, Austria and St. Anna Kinderspital, Vienna, Austria
Claire Berger, University Lyon, University Jean Monnet, INSERM, U 1059, Sainbiose and Hospitalier Univeristaire (CHU) Saint-Étienne, France 
Louis Bont, University Medical Center Utrecht, Utrecht, the Netherlands
Charlotte Demoor-Goldschmidt, Centre for Research in Epidemiology and Population Health, Cancer and Radiation team, University of Paris-Sud, Villejuif, France and CHU Angers, and Centre François Baclesse, Caen, France
Dimitri Diavatopoulos, Radboud University Medical Center, Nijmegen, the Netherlands
Mark Gaze, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, and University College London Hospital NHS Fundation Trust, London, United Kingdom
Andrew Gennery, Sir James Spence Professor of Child Health Professor and Honorary Consultant in Paediatric Immunology and HSCT Translational and Clinical Research Institute Newcastle University Great North Children’s Hospital Newcastle upon Tyne
Jennifer Heimall, The Children’s Hospital of Philadelphia, Philadelphia and Perelman School of Medicine at University of Pennsylvania, United States
Katerina Katsibardi, Aghia Sophia Children’s Hospital 1st Department of Paediatrics, University of Athens,  Athens, Greece
Michelle Kwok-Williams, Leeds Cancer Centre, St James’ Hospital, Leeds, United Kingdom
Arjan van Laarhoven, Radboud University Medical Center, Nijmegen, the Netherlands
Annechien Lambeck, University Medical Center Groningen, Groningen, the Netherlands
Matthew Matasar, Memorial Sloan Kettering Cancer Center, New York, United States
Audrone Mulevičiene, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
Anna Panasiuk, Medical University of Wroclaw, Wroclaw, Poland
Jelena Roganovic, Clinical Hospital Centre Rijeka, Rijeka, Croatia
Katrin Scheinemann, Kantonsspital Aaurau, Aarau, Switzerland
Brent Weil, Boston Children’s Hospital and Dana-Farber Cancer Center
Austen Worth, Great Ormond Street Hospital for Children NHS Foundation Trust, London,United Kingdom
Nicola Wright, University of Calgary, Calgary, Canada
Lorna Zadravec Zaletel, Institute of Oncology, Ljubljana, Slovenia